These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27020477)

  • 41. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
    Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N
    Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
    Lee S; Baxter DC; Limone B; Roberts MS; Coleman CI
    J Med Econ; 2012; 15(6):1088-96. PubMed ID: 22583065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
    Núñez C; Cénit MC; Alvarez-Lafuente R; Río J; Fernández-Arquero M; Arroyo R; Montalbán X; Fernández O; Oliver-Martos B; Leyva L; Comabella M; Urcelay E
    J Med Genet; 2014 Jun; 51(6):395-400. PubMed ID: 24748646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up regulation of MMP9 gene expression in female patients with multiple sclerosis.
    Hamedani SY; Taheri M; Sajjadi E; Omrani MD; Mazdeh M; Arsang-Jang S; Panah AS; Sayad A
    Hum Antibodies; 2016; 24(3-4):59-64. PubMed ID: 28128762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
    Løken-Amsrud KI; Holmøy T; Bakke SJ; Beiske AG; Bjerve KS; Bjørnarå BT; Hovdal H; Lilleås F; Midgard R; Pedersen T; Benth JS; Sandvik L; Torkildsen O; Wergeland S; Myhr KM
    Neurology; 2012 Jul; 79(3):267-73. PubMed ID: 22700809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allele and haplotype frequencies at human leukocyte antigen class I and II genes in Venezuela's population.
    Del Pilar Fortes M; Gill G; Paredes ME; Gamez LE; Palacios M; Blanca I; Tassinari P
    Ann Biol Clin (Paris); 2012; 70(2):175-81. PubMed ID: 22484528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.
    Minagar A; Adamashvili I; Kelley RE; Gonzalez-Toledo E; McLarty J; Smith SJ
    J Neuroinflammation; 2007 Jul; 4():16. PubMed ID: 17601341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.
    Comabella M; Craig DW; Morcillo-Suárez C; Río J; Navarro A; Fernández M; Martin R; Montalban X
    Arch Neurol; 2009 Aug; 66(8):972-8. PubMed ID: 19667218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrasting responses to interferon beta-1b treatment in relapsing-remitting multiple sclerosis: does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?
    van Boxel-Dezaire AH; van Trigt-Hoff SC; Killestein J; Schrijver HM; van Houwelingen JC; Polman CH; Nagelkerken L
    Ann Neurol; 2000 Sep; 48(3):313-22. PubMed ID: 10976637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis.
    Graves MC; Benton M; Lea RA; Boyle M; Tajouri L; Macartney-Coxson D; Scott RJ; Lechner-Scott J
    Mult Scler; 2014 Jul; 20(8):1033-41. PubMed ID: 24336351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-A, -B, and -DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China.
    Yang G; Deng YJ; Hu SN; Wu DY; Li SB; Zhu J; Zhu BF; Liu Y
    Tissue Antigens; 2006 Feb; 67(2):146-52. PubMed ID: 16441486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms of HLA genes in Western Javanese (Indonesia): close affinities to Southeast Asian populations.
    Yuliwulandari R; Kashiwase K; Nakajima H; Uddin J; Susmiarsih TP; Sofro AS; Tokunaga K
    Tissue Antigens; 2009 Jan; 73(1):46-53. PubMed ID: 19140832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study.
    Lugaresi A; Durastanti V; Gasperini C; Lai M; Pozzilli C; Orefice G; Sotgiu S; Pucci E; Ardito B; Millefiorini E;
    Clin Neuropharmacol; 2008; 31(3):167-72. PubMed ID: 18520983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human leukocyte antigen-A, -B, and -DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor-based population study.
    Assane AA; Fabricio-Silva GM; Cardoso-Oliveira J; Mabunda NE; Sousa AM; Jani IV; Ferreira OC; Porto LC
    Hum Immunol; 2010 Oct; 71(10):1027-32. PubMed ID: 20600444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA-frequencies of Austrian umbilical cord blood samples.
    Nerstheimer S; Tauscher P; Petek E; Schappacher-Tilp G
    Hum Immunol; 2015 Nov; 76(11):863-7. PubMed ID: 26431889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa.
    Testi M; Battarra M; Lucarelli G; Isgro A; Morrone A; Akinyanju O; Wakama T; Nunes JM; Andreani M; Sanchez-Mazas A
    Tissue Antigens; 2015 Oct; 86(4):285-92. PubMed ID: 26300115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.